ClinConnect ClinConnect Logo
Search / Trial NCT04449068

Observational Database on Deep Brain Stimulation in Tourette Syndrome

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jun 23, 2020

Trial Information

Current as of September 10, 2025

Recruiting

Keywords

Bilateral Deep Brain Stimulation Tourette Syndrome,

ClinConnect Summary

This clinical trial is studying the effects of deep brain stimulation (DBS) on individuals with Tourette syndrome, a condition that causes involuntary movements and sounds called tics. The researchers at Pitié-Salpêtrière Hospital in Paris are looking for patients who have severe Tourette syndrome that hasn’t responded to other treatments. If you’re eligible, you need to be willing to participate and be part of the French social security system.

Participants in the trial will be evaluated before the surgery and then once a year for five years after the DBS procedure. The study will look at how the treatment affects tic severity, any related mental health issues, overall quality of life, and cognitive functions. This information will help researchers understand how effective DBS is for people with Tourette syndrome and how it can improve their daily lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Tourette syndrome severe and drug-resistant eligible for bilateral deep brain stimulation
  • Person who voluntarily and knowledgeably agreed to participate in the study
  • Exclusion Criteria:
  • Non affiliation to a French social security system (recipient or assign) excluding AME

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials